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Abstract
Background: Leprosy still remains an important public health problem for many parts of the
world. An association of gangrene with leprosy is a rare one & can have a number of causative
mechanisms. We present a case with Leprosy & gangrene with positive anti phopholipid antibody
titers.
Case presentation: A 50-year-old non-diabetic, non-hypertensive lady presented with 2 months
history of progressive gangrene of bilateral toes. She was found to have madarosis &
hypopigmented, hypoaesthetic macular lesions on the upper limb & thighs. Bilateral ulnar &
popliteal nerves were thickened. A skin biopsy of the lesions revealed borderline tuberculoid
leprosy, slit skin smears revealed a bacteriological index of 1+. She did not have any evidence of
thromboembolic episode or atherosclerosis. ACLA was positive at presentation & also on another
occasion 6 weeks later. ACLAs were of the IgM type on both occasions. Lupus Anticoagulant & β2
GPI antibody were negative. DOPPLER of the lower limb arteries did not reveal any abnormality.
Patient was successfully treated with multi-drug antileprotics & anticoagulants.
Conclusion:  Infectious APLAs should be recognized as a cause of thrombosis in Leprosy.
Appropriate anticoagulation can salvage limb function.
Background
Leprosy still remains an important public health problem
for many parts of the world. An association of gangrene
with leprosy is a rare one & can have a number of causa-
tive mechanisms. We present a case with Leprosy & gan-
grene with positive anti phopholipid antibody titers.
Case presentation
A 50-year-old non-diabetic, non-hypertensive lady pre-
sented with 2 months history of progressive blackish dis-
coloration of the toes bilaterally. Examination revealed
gangrene of the Right great toe, 2nd toe & early gangrenous
changes in the 3rd toe. All the peripheral arteries were well
felt, there was no radiofemoral delay. There was no car-
diac murmur or a carotid bruit.
She was found to have madarosis & hypopigmented,
hypoaesthetic macular lesions on the upper limb &
thighs. Bilateral ulnar & popliteal nerves were thickened.
A skin biopsy of the lesions revealed borderline tubercu-
loid leprosy. Slit skin smears revealed a bacteriological
index of 1+. Erythrocyte sedimentation rate was 105, lipid
profile & fasting sugars were normal & anti neutrophil
cytoplsmic antibody (ANCA) negative.
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Anti Cardiolipin antibody (ACLA) was positive at presen-
tation (IgG-8; IgM-28.5; ELISA Genesis Diagnostics, Cam-
bridgeshire, UK) & also on another occasion 6 weeks later
(IgG-7.5; IgM-29; ELISA Genesis Diagnostics, Cambridge-
shire, UK). Thus, ACLAs were of the IgM type on both
occasions. Lupus Anticoagulant (PT, aPPT, Mixing studies,
DRVVT) & β2 GPI antibody were negative (IgG-1; IgM-
2.5; ELISA Genesis Diagnostics, Cambridgeshire, UK).
DOPPLER of the lower limb arteries did not reveal any
abnormality. Tests for other hypercoagulable states (pro-
tein C, protein S, Antithrombin III, homocystein, factor V
Leiden) were normal.
The patient improved with the multi drug anti leprotics &
anticoagulants. By 6 weeks, there was no progression of/
fresh gangrene & the pre gangrenous changes in the 3rd toe
had resolved.
Discussion
Antiphospholipid antibodies (APLA) are a group of
autoantibodies, which have been reported in Antiphos-
pholipid syndrome (APS), which is characterized by
raised levels of ACLA, thrombosis, recurrent fetal loss &
thrombocytopenia. APLA is a generic term that describes
closely related but not identical autoantibodies found in
APS: ACLA, anti β2 GPI & those with lupus anticoagulant
activity. The syndrome can occur in its primary form or
secondarily in association with other autoimmune disor-
ders. Although raised levels of these antibodies were first
reported only in autoimmune diseases, their prevalence is
now known to be more widespread. Elevated levels of
these antibodies have been found in various infections
like Syphillis, HIV disease, HCV disease, tuberculosis,
cytomegalovirus infection [1]. Loizou et al studied 112
leprosy patients & found elevated titers of APLA in 29%,
anti β2 GPI in 89%, & anti-Prothrombin in 21% of them
[2]. Initially, it seemed that infection induced APLA are
not associated with the thrombotic manifestations of APS.
This was attributed to the fact that the binding of autoim-
mune APLA to phospholipid is enhanced by the cofactor
β2 GPI (i.e. β2 GPI dependent) while the binding of infec-
tion induced APLA is not enhanced by this cofactor (i.e.
β2 GPI independent). Recent studies, however show that
the APLA in leprosy patients are heterogeneous with
respect to their β2 GPI requirement: in 10 of 31 leprosy
sera, the APLA were β2 GPI dependent & 16 of 31 were β2
GPI independent [3]. The clinical implications of this β2
GPI dependency are seen in Lucio's phenomenon in
which the histopathological findings are related to micro-
vascular thrombosis in the absence of inflammatory infil-
tration of the vessel wall. The β2 GPI dependency of APLA
in this condition has been confirmed by Levi et al [4].
Apart from this evidence of microscopic thrombosis,
frank gangrene in association with leprosy is a rare entity.
It has been hypothesized that certain infections in geneti-
cally predisposed individuals may induce these APLA.
Phospholipid binding peptides of bacterial & viral origin
that have structural similarity to the phospholipid sites
have been detected & found to induce APLA with proper-
ties similar to autoimmune APL in mice [5]. The elevated
levels of IgM subtype of APLA seen in our patient is in
accordance with other studies of APLA in leprosy [6,7].
Gangrene of the extremities in leprosy can have mecha-
nisms other than APLA alone. Vascular changes in the
form of intimal thickening & medial infiltration are
known to occur in leprosy. Embolisation & resultant graft-
ing of the Virchow cells has been found to lead to obstruc-
tion of the vessels [8]. Four such cases of arterial
obstruction have been described; 2 of them being occlu-
sion of the posterior tibial artery by lepromatous infiltra-
tion [9]. Arteriographic abnormalities such as occlusion,
narrowing, tortuosity, dilatation, poststenotic dilatation,
irregularity and incomplete filling of the lumen have been
found in the digital circulation in more than 75–94% of
leprosy patients [10].
Nerve trunk hypertrophy secondary to lepromatous proc-
ess can lead to arterial entrapment in the osteoligamen-
tous channels. This entrapment as well as the irritation of
sympathetic fibers can lead to spasm of the vessels &
resultant vascular compromise to the distal extremity.
This has been confirmed with angiography & reversal of
the spasm as well as the vascular compromise seen after
release of the roof of the osteoligamentous channel [8].
Gangrenous changes Figure 1
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Our patient did not have any clinical or laboratory mark-
ers of atherosclerosis or embolism, DOPPLER of the lower
limbs did not reveal any vascular obstruction involving
the medium size arteries. In the absence of any other
hypercoagulable states, APLA remains the most probable
cause of the digital gangrene.
Conclusion
Infectious APLA should be recognized as a cause of throm-
bosis in Leprosy. Appropriate anticoagulation can salvage
limb function. However, other mechanisms of gangrene
need careful evaluation & appropriate management.
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